Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans
- PMID: 15901750
- DOI: 10.1177/0091270004273493
Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans
Abstract
Alkamides are suspected to contribute to the activity of Echinacea preparations. They are mainly derived from undeca- and dodecanoic acid and differ in the degree of unsaturation and the configuration of the double bonds. In total, 6 alkamides have been isolated from the roots of Echinacea angustifolia as major lipophilic constituents and have been investigated regarding their pharmacokinetics. A sensitive and specific method has been developed for the identification and quantification of these alkamides in human plasma using liquid chromatography electrospray ionization ion-trap mass spectrometry. The method was applied to analyze plasma samples obtained from a randomized, open, single-dose, crossover study after oral administration of a 60% ethanolic extract from the roots of E. angustifolia to 11 healthy subjects. The maximum concentration of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides, the main alkamides in the roots of E. angustifolia, appeared already after 30 minutes and was 10.88 ng/mL for the 2.5-mL dose.
Similar articles
-
Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture.Planta Med. 2001 Dec;67(9):863-4. doi: 10.1055/s-2001-18846. Planta Med. 2001. PMID: 11745026
-
Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.Planta Med. 2011 Nov;77(16):1794-9. doi: 10.1055/s-0030-1271120. Epub 2011 May 20. Planta Med. 2011. PMID: 21604240
-
Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract.Phytomedicine. 2008 Aug;15(8):547-54. doi: 10.1016/j.phymed.2008.05.003. Epub 2008 Jun 25. Phytomedicine. 2008. PMID: 18583121
-
The role of alkamides as an active principle of echinacea.Planta Med. 2007 Jun;73(7):615-23. doi: 10.1055/s-2007-981531. Epub 2007 May 31. Planta Med. 2007. PMID: 17538868 Review.
-
Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.J Pharm Pharmacol. 2005 Aug;57(8):929-54. doi: 10.1211/0022357056127. J Pharm Pharmacol. 2005. PMID: 16102249 Review.
Cited by
-
Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review.Plants (Basel). 2022 May 5;11(9):1244. doi: 10.3390/plants11091244. Plants (Basel). 2022. PMID: 35567246 Free PMC article. Review.
-
A Comparison of the Immunostimulatory Effects of Polysaccharides from Tetraploid and Diploid Echinacea purpurea.Biomed Res Int. 2018 Jul 9;2018:8628531. doi: 10.1155/2018/8628531. eCollection 2018. Biomed Res Int. 2018. PMID: 30105254 Free PMC article.
-
Laboratory-derived formulations of Echinacea angustifolia roots lack preventive and treatment efficacy against experimental rhinovirus infections of healthy volunteers.Focus Altern Complement Ther. 2005 Dec;10(4):281-284. doi: 10.1211/fact.10.4.0007. Epub 2010 Jun 14. Focus Altern Complement Ther. 2005. PMID: 32313445 Free PMC article. No abstract available.
-
Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.Food Chem Toxicol. 2007 Dec;45(12):2359-65. doi: 10.1016/j.fct.2007.06.012. Epub 2007 Jun 15. Food Chem Toxicol. 2007. PMID: 17658211 Free PMC article.
-
Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cells.Planta Med. 2013 Mar;79(3-4):266-74. doi: 10.1055/s-0032-1328198. Epub 2013 Feb 13. Planta Med. 2013. PMID: 23408271 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources